Cargando…
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells
Targeted modulation of gene expression represents a valuable approach to understand the mechanisms governing gene regulation. In a therapeutic context, it can be exploited to selectively modify the aberrant expression of a disease-causing gene or to provide the target cells with a new function. Here...
Autores principales: | Mlambo, Tafadzwa, Nitsch, Sandra, Hildenbeutel, Markus, Romito, Marianna, Müller, Maximilian, Bossen, Claudia, Diederichs, Sven, Cornu, Tatjana I, Cathomen, Toni, Mussolino, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961145/ https://www.ncbi.nlm.nih.gov/pubmed/29538770 http://dx.doi.org/10.1093/nar/gky171 |
Ejemplares similares
-
RTEL1 is required for silencing and epigenome stability
por: Olivier, Margaux, et al.
Publicado: (2023) -
TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
por: Mussolino, Claudio, et al.
Publicado: (2014) -
Transcriptional provirus silencing as a crosstalk of de novo DNA methylation and epigenomic features at the integration site
por: Šenigl, Filip, et al.
Publicado: (2012) -
Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing
por: O’Geen, Henriette, et al.
Publicado: (2022) -
The comprehensive epigenome map of piRNA clusters
por: Kawaoka, Shinpei, et al.
Publicado: (2013)